Common side effects when taken by mouth include nausea, diarrhea, headache, cough, rash, and elevated liver enzymes. Terbinafine was discovered in Terbinafine is mainly effective on the dermatophyte ...

Terbinafine is an antifungal activity, which is prescribed for the treatment of advanced infections of the processes. The dose is one tablet, to be prescribed daily at around the same time and either ...

The FDA today approved the first generic versions of Novartis’ Lamisil (terbinafine hydrochloride) tablets, used to treat nail fungus infection (onychomycosis). The agency approved applications from ...

May 9, 2001 — The Food and Drug Administration (FDA) has issued a public health advisory concerning Sporanox (itraconazole) Capsules and Lamisil (terbinafine hydrochloride) tablets for the treatment ...

Discontinue using terbinafine tablets if these reactions occur. Advise patients to report to their physician if any of the following symptoms occur: hives, mouth sores, blistering and peeling of skin, ...

New York (MedscapeWire) May 11 —The US Food and Drug Administration (FDA) has issued a public health advisory on the safety of itraconazole (Sporanox) products and terbinafine hydrochloride (Lamisil) ...

Mar. 23 -- FRIDAY, Oct. 5 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new oral form of the Novartis drug Lamisil (terbinafine hydrochloride) to treat people age 4 years ...

Mar. 23 -- THURSDAY, July 5 (HealthDay News) -- The first generic versions of prescription Lamisil (terbinafine hydrochloride), used to treat fungal infections of the toenail or fingernail, have been ...

JERUSALEM, July 3 (UPI) -- Teva said Tuesday the U.S. Food and Drug Administration approved its generic formulation of Novartis' anti-fungal agent, Lamisil tablets. Teva said it will immediately begin ...

WASHINGTON, July 2 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Lamisil (terbinafine hydrochloride) tablets to treat nail fungus infection. "This approval ...